HHS, Cohen Foundation Award $1M to Lyme Disease Dx Research Projects
The funding is being provided to 10 groups through the LymeX Diagnostics Prize initiative, which was launched in late 2020 by theHHS- and Cohen Foundation-backed Lyme Innovation Accelerator.
NanoMosaic Licenses Post-Operative Delirium Test From Mass General, Harvard Medical School
The test uses NanoMosiac's nanoneedle technology to diagnose patients with anesthesia-induced delirium and Alzheimer's disease.
Beckman Coulter Partners With Mass General to Evaluate Pediatric Infection Dx
Using funding from BARDA, the partners will examine whether Beckman's monocyte distribution width assay can predict early sepsis in children.
The data, while limited, indicate that the firm's blood-only assay may be able to match the performance of existing commercial tissue-informed competitors.
ACMG Presentation Highlights Broad Institute's Massive Expansion of COVID-19 Testing Program
The Broad's clinical research sequencing lab now runs 135,000 tests each day and routinely tests more than 100 higher education sites and 40 schools in the state.